Business TerrAscend becomes first major US pot operator on Apple App Store The rollout will start at select dispensaries in New Jersey and California Nick LabaMarch 15, 2022
Business Q3 sales slow for TerrAscend But net income soared due to a US$69M value gain on warrants Nick LabaNovember 16, 2021
Industry update TerrAscend reports record Q4 sales, drops CEO Despite cannabis sales reaching $198.3M in 2020, CEO Jason Ackerman is stepping down Jared GnamMarch 23, 2021
Analysis Canopy shares surge on 2022 profit prediction Despite reporting a $829M Q3 loss, shares are up as the Canadian weed giant predicts US legalization will spur profits Jared GnamFebruary 9, 2021
Industry update TerrAscend expands gummy recall following complaints ‘alleging’ mould The company says it proactively initiated the recall of 330K units after receiving consumer complaints alleging mould on its Haven St. gummies Nick LabaFebruary 1, 2021
Industry update TerrAscend opens its first New Jersey store as adult-use sales loom Being one of only a few cannabis operators in New Jersey's medical market, TerrAscend prepares for state-legal adult-use sales in 2021 Jared GnamNovember 24, 2020
Analysis Pot stock leaders to consider ahead of US election: BCMI Analyst Chris Damas gives investors his industry leaders in Canada and the U.S., which could win big if Democrats take power Jared GnamOctober 28, 2020
The weed wire TerrAscend revenues rise as Pennsylvania market blooms Surging demand for medical weed in Pennsylvania helped drive the company's Q2 net revenues to $47.2 million Jared GnamAugust 20, 2020
The weed wire EBITDA profitability a ‘transformational milestone’ for TerrAscend TerrAscend's strategy of focusing on US markets continue to pay off Nick LabaMay 28, 2020
Canada Hedging bets on US market paying off for TerrAscend Stateside sales accounted for 93% of revenues in the last quarter of 2019 Nick LabaApril 24, 2020